⌘K

Login Start Free

Home/Filings/4/0001493152-23-019557

4//SEC Filing

Trieu Vuong 4

Accession 0001493152-23-019557

CIK 0000908259other

View on SEC.gov Company Profile

Filed

May 30, 8:00 PM ET

Accepted

May 31, 9:39 AM ET

Size

6.2 KB

Accession

0001493152-23-019557

Insider Transaction Report

Form 4

Period: 2023-05-26

Oncotelic Therapeutics, Inc.OTLC

DirectorCHAIRMAN AND CEO10% Owner

Transactions

Purchase
Common Stock
2023-05-26$0.03/sh+126,888$4,327→ 91,044,217 total

Holdings

Common Stock
(indirect: By Autotelic, Inc.)
16,780,384
Common Stock
(indirect: By Spouse)
6,872,529

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncotelic Therapeutics, Inc.

CIK 0000908259

Entity typeother

Related Parties

1

filerCIK 0001587074

Filing Metadata

Form type: 4
Filed: May 30, 8:00 PM ET
Accepted: May 31, 9:39 AM ET
Size: 6.2 KB

View on SEC.gov